Cargando…

Promising trends in lung cancer care, but are we overlooking the majority?

Detalles Bibliográficos
Autores principales:	Sharma, Bhavina, Ganti, Apar Kishor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522388/ https://www.ncbi.nlm.nih.gov/pubmed/37665677 http://dx.doi.org/10.18632/aging.204662

Ejemplares similares

Cisplatin or carboplatin for advanced non-small cell lung cancer: does it really matter?
por: Kesireddy, Meghana, et al.
Publicado: (2021)

Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
por: Yellala, Amulya, et al.
Publicado: (2020)

EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
por: Reade, Chad A, et al.
Publicado: (2009)

Current concepts in the management of small cell lung cancer
por: Ganti, Apar Kishor, et al.
Publicado: (2013)

Are we overlooking the qualitative ‘look' of obesity?
por: Perez, A, et al.
Publicado: (2015)

Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database
por: Anggondowati, Trisari, et al.
Publicado: (2020)

Smoking and COVID-19: Did we overlook representativeness?
por: Wenzl, Thomas
Publicado: (2020)

Video Urodynamics in the Digital Age: What Have We Overlooked?
por: Lee, Tack, et al.
Publicado: (2023)

Clinical Utility of Mobocertinib in the Treatment of NSCLC – Patient Selection and Reported Outcomes
por: Arnold, Abram, et al.
Publicado: (2023)

Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non–small-cell lung cancer in the USA
por: Li, Yulin, et al.
Publicado: (2019)

Correction: Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA
por: Li, Yulin, et al.
Publicado: (2019)

Risk factors of SARS-CoV-2 infection and complications from COVID-19 in lung cancer patients
por: Ganti, Apar Kishor, et al.
Publicado: (2023)

Pancytopenia due to iron deficiency worsened by iron infusion: a case report
por: Ganti, Apar Kishor, et al.
Publicado: (2007)

Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma
por: Macha, Muzafar A, et al.
Publicado: (2013)

RNA-based therapies: A cog in the wheel of lung cancer defense
por: Khan, Parvez, et al.
Publicado: (2021)

The overlooked issue in US unemployment
por: Gordon, Edward E.
Publicado: (2014)

Autopsy kidneys: an overlooked resource
por: Henriksen, Kammi J
Publicado: (2018)

Skeletal Muscle Should Not Be Overlooked
por: Seo, Ji A
Publicado: (2021)

Real‐world outcomes of anti‐EGFR therapy in advanced non–small cell lung cancer EGFR mutated in Peru
por: Galvez‐Nino, Marco, et al.
Publicado: (2022)

Systemic inflammation is associated with inferior disease control and survival in stage III non-small cell lung cancer
por: Keit, Emily, et al.
Publicado: (2021)

Characteristics of toxicity occurrence patterns in concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced non-small cell lung cancer: a pooled analysis based on individual patient data of CALGB/Alliance trials
por: Yang, Lexie Zidanyue, et al.
Publicado: (2022)

HER-2/neu and CD117 (c-kit) overexpression in patients with pesticide exposure and extensive stage small cell lung carcinoma (ESSCLC)
por: Potti, Anil, et al.
Publicado: (2005)

Treatment of Essential Tremor: Are there Issues We are Overlooking?
por: Louis, Elan D.
Publicado: (2012)

Polycystic ovary syndrome. Are we overlooking something?
por: Tekin, Abdullah
Publicado: (2016)

Are we overlooking alcohol use by younger children?
por: Skylstad, Vilde, et al.
Publicado: (2022)

Weight Loss and Percutaneous Endoscopic Gastrostomy Tube Placement during Chemoradiotherapy for Locally Advanced Cancer of the Oropharynx Do Not Negatively Impact Outcomes
por: Baine, Michael J., et al.
Publicado: (2017)

Comorbidity and concurrence of problems: Overlooked, not under-researched
por: Hellman, Matilda
Publicado: (2019)

Exertional Chest Pain and Dyspnea From Hyperviscosity Syndrome Related to Marginal Zone Lymphoma
por: Dhakal, Prajwal, et al.
Publicado: (2014)

Child Injury Prevention: An Overlooked Challenge for Child Survival
por: Meddings, David
Publicado: (2013)

The Respiratory Drive: An Overlooked Tile of COVID-19 Pathophysiology
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Treatment burden is important to patients but often overlooked by clinicians
por: Dobler, Claudia C.
Publicado: (2021)

Helicobacter pylori: Have potential benefits been overlooked?
por: Schubert, Jonathon P, et al.
Publicado: (2022)

Lung Cancer Risk and Delivering on the Promise of the Genomic Era
por: Arenberg, Douglas
Publicado: (2023)

Characterizing Immune Checkpoint Inhibitor-Induced Hypophysitis and Obstacles in Diagnosis
por: Johnson, Jake, et al.
Publicado: (2021)

Nanosponges: An overlooked promising strategy to combat SARS-CoV-2
por: Mostafavi, Ebrahim, et al.
Publicado: (2022)

Researching multimorbidity in hospital: can we deliver on the promise of health informatics?
por: Witham, Miles D., et al.
Publicado: (2023)

Drug–drug Interactions: An Overlooked Dimension of the COVID-19 Pandemic
por: Beninger, Paul
Publicado: (2023)

Protecting Gastroenterologists through Rehabilitation Training: An Overlooked Area of Concern
por: Ko, Sun-Hye, et al.
Publicado: (2023)

Asthmatic airway remodeling: long overlooked but too important to ignore
por: Tatler, Amanda L.
Publicado: (2022)

Attention deficit hyperactivity disorder and eating disorders: an overlooked comorbidity?
por: Soutullo Esperón, C.A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hladgeqoqr9qm4nji3ilpq2060